Better Cures through Discovery Research
My team and I investigate childhood leukaemia, the cause of more deaths than any other malignancy in children. Our research into this disease is driven by challenges observed in the clinic. We integrate these observations with translational research efforts with the aim to develop novel therapies.
The current project aims to identify candidate drugs, approved for clinical use, that have unanticipated, or "off target" anti-leukaemia properties. This process is called drug repositioning. The potential and cost-effectiveness of this approach offers real hope for the discovery of novel anti-cancer therapies.